Thus, transfection of FPR in an FPR− subclone of GBM line enabled these cells to exhibit full agonist-induced responses as shown by tumour cells constitutively expressing FPR (Zhou et al, 2005; Huang et al, 2007). This evidence concerns the gene FPR1 and glioblastoma.